Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Flaviroz 35mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Eswar Therapeutics Pvt Ltd

Salt Composition

Trimetazidine (35mg)

Overview Flaviroz 35mg Tablet MR

Cardiogard 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain stemming from heart conditions. This medication acts to prevent future angina episodes but won't alleviate an attack already in progress. It's suitable for monotherapy or use alongside other cardiac medications. As directed by your physician, take Cardiogard 35mg ER tablets consistently, with or without food, at the same time each day. Dosage frequency is determined by your doctor and may adjust based on treatment effectiveness. Continuous use, even when feeling well, is vital for optimal preventative benefits. Discontinuing treatment may trigger a recurrence of chest pain. Complementary lifestyle modifications – such as smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – can further enhance cardiovascular health. Potential side effects, including nausea, vomiting, headache, dizziness, abdominal discomfort, diarrhea, skin rashes (itching, hives), and general weakness, may occur. Consult your doctor if these persist or are bothersome. Prior to initiating Cardiogard 35mg ER therapy, disclose any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medications to your healthcare provider, as this medication may not be appropriate for all individuals.

Uses of Flaviroz 35mg Tablet MR

Managing Chest Pain Associated with Coronary Artery Disease

Major Benefits of Flaviroz 35mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. The Flaviroz 35mg Modified-Release Tablet should be administered with food.

Common Side effects of Flaviroz 35mg Tablet MR:

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Weakness
  • Rash
  • Abdominal pain
  • Indigestion
  • Itching
  • Diarrhea
  • Hives

How to use Flaviroz 35mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Flaviroz 35mg Modified-Release Tablet should be administered with a meal.

How Flaviroz 35mg Tablet MR works:

Flaviroz 35mg Modified-Release tablets offer anti-anginal benefits. By altering cardiac metabolism, favoring glucose over fats as fuel, they reduce the heart's oxygen demand, thus improving cardiac efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Flaviroz 35mg modified-release tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Flaviroz 35mg Tablet MR use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Flaviroz 35mg Tablet MR with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Flaviroz 35mg Modified-Release Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Flaviroz 35mg modified-release tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Flaviroz 35mg modified-release tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Flaviroz 35mg MR tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Flaviroz 35mg Tablet MR :

Should you forget to take a Flaviroz 35mg Tablet MR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Flaviroz 35mg Tablet MR

LabelValue
Chemical Classification Benzylamines
Developing Habits No.
Treatment Category Heart
Action Class Fatty acid modulator and sodium channel inhibitor

FAQs on Flaviroz 35mg Tablet MR

Flaviroz 35mg MR tablets are not beta-blockers. This anti-anginal medication, used alongside other treatments, helps manage angina pectoris (chest pain from coronary artery disease) by safeguarding heart cells from oxygen deprivation during angina attacks.
Avoid Flaviroz 35mg Tablet MR if you're allergic to it, have severe kidney disease, or have Parkinson's disease. Parkinson's disease is a neurological disorder affecting movement, characterized by tremors, rigidity, slow movement, and impaired gait.
Flaviroz 35mg MR tablets require careful use in patients over 75. Elderly patients typically receive lower doses to minimize adverse reactions, necessitating close monitoring.
Flaviroz 35mg Tablet MR may rarely cause falls, potentially due to gait instability or postural hypotension. Elderly patients may be at increased risk and require closer monitoring and caution.
Flaviroz 35mg MR Tablets may cause dizziness and drowsiness. Avoid driving or operating machinery if affected.
Take Flaviroz 35mg MR tablets precisely as your doctor instructs. Swallow the tablets whole with enough liquid, such as water. This medication may be taken with or without food.
Flaviroz 35mg Tablet MR may cause common side effects such as dizziness, headache, abdominal pain, diarrhea, indigestion, rash, itching, and hives, along with nausea and weakness. Rarely, it can lead to palpitations, orthostatic hypotension (causing dizziness, lightheadedness, or fainting), falls, and flushing.
Flaviroz 35mg Tablet MR
111
MRP 135
17% off